Phenotypic and Genotypic Characterization of Extended Spectrum β-lactamase Producing Gram Negative Bacterial Species Isolated from Blood Samples of Intensive Care Unit Patients
DOI:
https://doi.org/10.31729/jnma.v64i299.9550Keywords:
bacteremia, combined disc synergy test, extended-spectrum beta-lactamase, gram-negative bacteria, polymerase chain reactionAbstract
Introduction: Extended Spectrum beta lactamase producing gram negative bacteria are global concern as they harbour plasmid mediated enzymes encoded by blaTEM, blaCTX-M and blaSHV genes.
Methods: Blood samples were received from patients admitted in various ICUs of Adesh hospital. Identification and antimicrobial susceptibility testing was done by Vitek 2 compact system. Phenotypic detection of ESBL production was done by Combined disc synergy test. Single PCR was used for detection of blaCTX-M, blaTEM and blaSHV genes.
Results: Out of total 1875 blood samples processed, 120 blood samples showed bacterial growth. Prevalence of bacteremia was recorded as 120 (6.40%). 1196 (63.77%) patients were males and 679 (56.77%) were females, 76 (6.35%) bacteremia recorded from male patients and 44 (6.48%) from female patients. The prevalence of blood stream infection was seen 20 (9.52%) in SICU. Out of 120 bacterial growths, 75 identified as E. coli 29 (38.66%), K. pneumoniae 27 (36%), P. aeruginosa 07 (9.33%), A. baumannii 12 (16%). 33 (44%) were recorded as ESBL producers and 42 (56%) isolates were non-Extended Spectrum beta lactamase producers. Out of 33 phenotypically positive Extended Spectrum beta lactamase producer isolates, blaTEM gene was detected 22 (66.66%) followed by blaCTX-M 21 (63.63%).
Conclusions: Extended Spectrum beta lactamase detection has less use in clinical management rather it is important to identify epidemiological linkages. For clinicians, recurrent isolation of Extended Spectrum beta lactamase producing organisms’ isolation from ICUs may be an issue related to Infection Prevention and Control.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.
